Drug Profile
Sabeluzole
Alternative Names: Arbetuzole; R 58735Latest Information Update: 26 Sep 2006
Price :
$50
*
At a glance
- Originator Janssen L.P.
- Class Neuroprotectants; Nootropics
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Diabetic neuropathies
Most Recent Events
- 08 Jan 2001 Discontinued-Clinical for Alzheimer's disease in United Kingdom (PO)
- 08 Jan 2001 Discontinued-II for Alzheimer's disease in Canada (PO)
- 08 Jan 2001 Discontinued-III for Alzheimer's disease in Belgium (PO)